A comparative longitudinal quality of life study using the Spitzer quality of life index in a randomized multicenter phase III trial (FFCD 9102): chemoradiation followed by surgery compared with chemoradiation alone in locally advanced squamous resectable

Date publication

mai 2006

Journal

Annals of oncology : official journal of the European Society for Medical Oncology

Auteurs

Membres identifiés du Cancéropôle Est :
Pr BEDENNE Laurent , Pr BOUCHE Olivier , Pr CONROY Thierry

Tous les auteurs :
Bonnetain F, Bouché O, Michel P, Mariette C, Conroy T, Pezet D, Roullet B, Seitz JF, Paillot B, Arveux P, Milan C, Bedenne L

Lien Pubmed

https://www.ncbi.nlm.nih.gov/pubmed/16524973

Résumé

The aim of the study was to compare the longitudinal quality of life (QoL) between chemoradiation with or without surgery in patients with locally advanced squamous resectable esophageal cancer included in a randomized multicenter phase III trial (FFCD 9102).

Mots clés

Adenocarcinoma, drug therapy, Antineoplastic Combined Chemotherapy Protocols, therapeutic use, Carcinoma, Squamous Cell, drug therapy, Combined Modality Therapy, Esophageal Neoplasms, drug therapy, Esophagectomy, Female, Follow-Up Studies, Humans, Longitudinal Studies, Male, Middle Aged, Quality of Life, Radiotherapy Dosage, Survival Rate

Référence

Ann. Oncol.. 2006 May;17(5):827-34